3/23/2026

Ketorolac Injection

Products Affected - Description

- Ketorolac injection, Baxter, 30 mg/mL, 1 mL vial, 25 count, NDC 00338-0072-25
- Ketorolac injection, Camber, 15 mg/mL, 1 mL vial, 25 count, NDC 31722-0305-25
- Ketorolac injection, Camber, 30 mg/mL, 1 mL vial, 25 count, NDC 31722-0306-25
- Ketorolac injection, Camber, 30 mg/mL, 2 mL for intramuscular use vial, 25 count, NDC 31722-0307-25 - discontinued
- Ketorolac injection, Fresenius Kabi, 30 mg/mL, 1 mL RFID Smart Label prefilled syringe, 24 count, NDC 76045-0209-10
- Ketorolac injection, Fresenius Kabi, 30 mg/mL, 1 mL vial, 25 count, NDC 63323-0162-01
- Ketorolac injection, Fresenius Kabi, 30 mg/mL, 2 mL for intramuscular use vial, 25 count, NDC 63323-0162-02
- Ketorolac injection, Glenmark, 15 mg/mL, 1 mL vial, 25 count, NDC 68462-0755-25
- Ketorolac injection, Glenmark, 30 mg/mL, 2 mL for intramuscular use vial, 25 count, NDC 68462-0757-25
- Ketorolac injection, Pfizer, 15 mg/mL, 1 mL vial, 25 count, NDC 00409-3793-01
- Ketorolac injection, Pfizer, 15 mg/mL, 1 mL vial, 25 count, NDC 00409-3793-25
- Ketorolac injection, Pfizer, 30 mg/mL, 1 mL vial, 25 count, NDC 00409-3795-25
- Ketorolac injection, Pfizer, 30 mg/mL, 1 mL vial, 25 count, NDC 00409-3795-01
- Ketorolac injection, Pfizer, 30 mg/mL, 2 mL for intramuscular use vial, 10 count, NDC 00409-3796-01
- Ketorolac injection, Pfizer, 30 mg/mL, 2 mL for intramuscular use vial, 25 count, NDC 00409-3796-25
- Ketorolac injection, Sola, 15 mg/mL, 1 mL vial, 25 count, NDC 70512-0842-25
- Ketorolac injection, Sola, 30 mg/mL, 1 mL vial, 25 count, NDC 70512-0843-25
- Ketorolac injection, Sola, 30 mg/mL, 2 mL for intramuscular use vial, 25 count, NDC 70512-0844-25

Reason for the Shortage

- Alembic has ketorolac injection available.
- Baxter did not provide a reason for the shortage.
- Camber did not provide a reason for the shortage. Ketorolac 30 mg/mL 2 mL intramuscular injection is discontinued.
- Caplin Steriles has ketorolac injection available.
- Fosun Pharma has ketorolac injection available.
- Fresenius Kabi did not provide a reason for the shortage.
- Glenmark did not provide a reason for the shortage.
- Pfizer has ketorolac injection on shortage due to manufacturing delays and increased demand.
- Sagent has ketorolac injection available.
- Sola did not provide a reason for the shortage.

Available Products

- Ketorolac injection, Caplin Steriles USA, 15 mg/mL, 1 mL vial, 25 count, NDC 65145-0146-25
- Ketorolac injection, Caplin Steriles USA, 30 mg/mL, 1 mL vial, 25 count, NDC 65145-0145-25
- Ketorolac injection, Caplin Steriles USA, 30 mg/mL, 2 mL for intramuscular use vial, 25 count, NDC 65145-0147-25
- Ketorolac injection, Fosun Pharma, 30 mg/mL, 1 mL vial, 25 count, NDC 72266-0118-25
- Ketorolac injection, Fosun Pharma, 30 mg/mL, 2 mL for intramuscular use vial, 25 count, NDC 72266-0119-25
- Ketorolac injection, Fresenius Kabi, 15 mg/mL, 1 mL prefilled syringe, 24 count, NDC 76045-0107-10
- Ketorolac injection, Fresenius Kabi, 15 mg/mL, 1 mL vial, 25 count, NDC 63323-0161-01
- Ketorolac injection, Fresenius Kabi, 30 mg/mL, 1 mL prefilled syringe, 24 count, NDC 76045-0104-10
- Ketorolac injection, Fresenius Kabi, 30 mg/mL, 2 mL for intramuscular use prefilled syringe, 24 count, NDC 76045-0105-20
- Ketorolac injection, Sagent, 15 mg/mL, 1 mL vial, 25 count, NDC 25021-0700-01
- Ketorolac injection, Sagent, 30 mg/mL, 1 mL vial, 25 count, NDC 25021-0701-01
- Ketorolac injection, Sagent, 30 mg/mL, 2 mL for intramuscular use vial, 25 count, NDC 25021-0701-02

Estimated Resupply Dates

- Baxter has ketorolac 30 mg/mL 1 mL vials in limited supply.
- Camber has ketorolac 15 mg/mL 1 mL vials on back order and the company estimates a release date in early-April 2026. The 30 mg/mL 1 mL vials are on allocation.
- Fresenius Kabi has ketorolac 30 mg/mL 1 mL RFID prefilled syringes available with short expiration dating (< 7 months). The 30 mg/mL 1 mL vials and 30 mg/mL 2 mL vials are on back order and the company estimates a release date in mid-April 2026.
- Glenmark has ketorolac 15 mg/mL 1 mL vials and 30 mg/mL 2 mL vials available with short expiration dating.
- Pfizer has ketorolac 15 mg/mL 1 mL vials (00409-3793-25) on back order and the company estimates a release date of June 2027. The 30 mg/mL 1 mL vials (00409-3795-25) and 2 mL vials (00409-3796-25) are available in limited supply with short dating. Ketorolac 15 mg/mL 1 mL vials (00409-3793-01), 30 mg/mL 1 mL vials (00409-3795-01), and 30 mg/mL 2 mL vials (00409-3796-25) are on long-term back order and the company cannot estimate a release date.
- Sola has temporarily discontinued ketorolac injection.

Updated

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.